These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34915593)
1. Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome. Riley RD; Collins GS; Ensor J; Archer L; Booth S; Mozumder SI; Rutherford MJ; van Smeden M; Lambert PC; Snell KIE Stat Med; 2022 Mar; 41(7):1280-1295. PubMed ID: 34915593 [TBL] [Abstract][Full Text] [Related]
2. Minimum sample size for external validation of a clinical prediction model with a binary outcome. Riley RD; Debray TPA; Collins GS; Archer L; Ensor J; van Smeden M; Snell KIE Stat Med; 2021 Aug; 40(19):4230-4251. PubMed ID: 34031906 [TBL] [Abstract][Full Text] [Related]
3. Minimum sample size for external validation of a clinical prediction model with a continuous outcome. Archer L; Snell KIE; Ensor J; Hudda MT; Collins GS; Riley RD Stat Med; 2021 Jan; 40(1):133-146. PubMed ID: 33150684 [TBL] [Abstract][Full Text] [Related]
4. Estimation of required sample size for external validation of risk models for binary outcomes. Pavlou M; Qu C; Omar RZ; Seaman SR; Steyerberg EW; White IR; Ambler G Stat Methods Med Res; 2021 Oct; 30(10):2187-2206. PubMed ID: 33881369 [TBL] [Abstract][Full Text] [Related]
8. An evaluation of sample size requirements for developing risk prediction models with binary outcomes. Pavlou M; Ambler G; Qu C; Seaman SR; White IR; Omar RZ BMC Med Res Methodol; 2024 Jul; 24(1):146. PubMed ID: 38987715 [TBL] [Abstract][Full Text] [Related]
9. Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Riley RD; Snell KI; Ensor J; Burke DL; Harrell FE; Moons KG; Collins GS Stat Med; 2019 Mar; 38(7):1276-1296. PubMed ID: 30357870 [TBL] [Abstract][Full Text] [Related]
10. A note on estimating the Cox-Snell R Riley RD; Van Calster B; Collins GS Stat Med; 2021 Feb; 40(4):859-864. PubMed ID: 33283904 [TBL] [Abstract][Full Text] [Related]
11. Prognostic models for identifying risk of poor outcome in people with acute ankle sprains: the SPRAINED development and external validation study. Keene DJ; Schlüssel MM; Thompson J; Hagan DA; Williams MA; Byrne C; Goodacre S; Cooke M; Gwilym S; Hormbrey P; Bostock J; Haywood K; Wilson D; Collins GS; Lamb SE Health Technol Assess; 2018 Nov; 22(64):1-112. PubMed ID: 30474592 [TBL] [Abstract][Full Text] [Related]
12. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation? Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107 [TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
14. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis. Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645 [TBL] [Abstract][Full Text] [Related]
15. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation. Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D; Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848 [TBL] [Abstract][Full Text] [Related]
16. Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study. Archer L; Koshiaris C; Lay-Flurrie S; Snell KIE; Riley RD; Stevens R; Banerjee A; Usher-Smith JA; Clegg A; Payne RA; Hobbs FDR; McManus RJ; Sheppard JP; BMJ; 2022 Nov; 379():e070918. PubMed ID: 36347531 [TBL] [Abstract][Full Text] [Related]
17. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation. Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338 [TBL] [Abstract][Full Text] [Related]
18. Sample size considerations for the external validation of a multivariable prognostic model: a resampling study. Collins GS; Ogundimu EO; Altman DG Stat Med; 2016 Jan; 35(2):214-26. PubMed ID: 26553135 [TBL] [Abstract][Full Text] [Related]
19. Minimum sample size for developing a multivariable prediction model: Part I - Continuous outcomes. Riley RD; Snell KIE; Ensor J; Burke DL; Harrell FE; Moons KGM; Collins GS Stat Med; 2019 Mar; 38(7):1262-1275. PubMed ID: 30347470 [TBL] [Abstract][Full Text] [Related]